Edition:
United States

ImmuCell Corp (ICCC.OQ)

ICCC.OQ on NASDAQ Stock Exchange Capital Market

9.21USD
10:04am EST
Change (% chg)

$0.04 (+0.44%)
Prev Close
$9.17
Open
$9.24
Day's High
$9.24
Day's Low
$9.21
Volume
404
Avg. Vol
2,331
52-wk High
$9.24
52-wk Low
$5.00

Chart for

About

ImmuCell Corporation is an animal health company. The Company operates in the development, acquisition, manufacture and sale of products that improve the health and productivity of cows for the dairy and beef industries segment. The Company has developed products that provide immediate immunity to newborn dairy and beef cattle,... (more)
No analyst recommendations are available for .

Overall

Beta: 1.13
Market Cap(Mil.): $46.32
Shares Outstanding(Mil.): 5.05
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 200.71 15.46
EPS (TTM): -- -- --
ROI: -- -10.20 11.85
ROE: -- -36.19 15.83

BRIEF-Immucell Q3 loss per share $0.07

* Immucell announces financial results for third quarter of 2017

Nov 13 2017

BRIEF-ImmuCell announces expansion of sales and marketing team

* ImmuCell Corp - ‍during Q4 of 2017, company expects to achieve regulatory approval of First Defense Tri-Shield​

Sep 13 2017

BRIEF-ImmuCell Q2 loss per share $0.05

* ImmuCell announces financial results for second quarter of 2017

Aug 14 2017

BRIEF-Immucell enters into amendment to agreement with Plas-Pak Industries

* On July 24, co entered into amendment to agreement with Plas-Pak Industries of Norwich, Connecticut, originally dated as of January 4, 2010

Jul 25 2017

Competitors

  Price Chg
Merck & Co., Inc. (MRK.N) $54.46 +0.19
Pfizer Inc. (PFE.N) $35.49 -0.05
Eli Lilly and Co (LLY.N) $84.15 +0.64

Earnings vs. Estimates

No consensus analysis data available.